Cochrane Systematic Review: Treatment of Lennox-Gastaut syndrome

OBJECTIVES: To compare the effects of pharmaceutical therapies used to treat LGS
in terms of control of seizures and adverse effects. Many people who suffer from
this syndrome will already be receiving other antiepileptic medications at the
time of their entry into a trial. However, for the purpose of this review we will
only consider the effect of the single therapeutic agent being trialled (often as
add-on therapy).

OBJECTIVES: To compare the effects of pharmaceutical therapies used to treat LGS
in terms of control of seizures and adverse effects. Many people who suffer from
this syndrome will already be receiving other antiepileptic medications at the
time of their entry into a trial. However, for the purpose of this review we will
only consider the effect of the single therapeutic agent being trialled (often as
add-on therapy).

Cochrane Systematic Review: Treatment of Lennox-Gastaut syndrome

OBJECTIVES: To compare the effects of pharmaceutical therapies used to treat LGS
in terms of control of seizures and adverse effects. Many people who suffer from
this syndrome will already be receiving other antiepileptic medications at the
time of their entry into a trial. However, for the purpose of this review we will
only consider the effect of the single therapeutic agent being trialled (often as
add-on therapy).

OBJECTIVES: To compare the effects of pharmaceutical therapies used to treat LGS
in terms of control of seizures and adverse effects. Many people who suffer from
this syndrome will already be receiving other antiepileptic medications at the
time of their entry into a trial. However, for the purpose of this review we will
only consider the effect of the single therapeutic agent being trialled (often as
add-on therapy).